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ABSTRACT 
A mesenchymal-epithelial cell interaction exists in the testis be- 
tween the Sertoli cells that form the seminiferous tubule and the 
mesenchymal-derived peritubular myoid cells that surround the tu- 
bule. Analysis of the mesenchymal-epithelial interactions between 
these cells revealed the local production of a mesenchymal factor, 
PModS. PModS modulates the differentiated functions of Sertoli cells 
in uitro, including stimulation of the iron-binding protein transferrin 
(Tf). Previous results have indicated that PModS-induced Tf gene 
expression involves the activation of immediate early genes. One of 
the immediate early genes was identified as c-fos. The importance of 
c-fos was demonstrated in the current study when a c-fos antisense 
oligonucleotide was found to inhibit the ability of PModS to induce the 
expression of a Tf promoter-chloramphenicol acetyltransferase (CAT) 
construct. The regulation of c-fos by PModS was investigated with 
various CAT constructs containing segments of the c-fos promoter, 
such as the serum response element (SRE), .&-inducible element 
(SIE), CAMP response element (CRE), and phorbol ester/TPA re- 
sponse element (TRE), transfected into cultured Sertoli cells. PModS 
has no effect on CAMP response element-CAT or TRE-CAT, suggest- 
ing that PModS does not act through stimulation of CAMP and protein 
kinase C pathways. PModS was found to activate the c-fos SRE-CAT 
construct and the SIE-CAT construct. A construct containing both 
SIE and SRE was stimulated to the same degree as either element 
alone. Gel mobility shift assays using nuclear extracts from PModS- 
stimulated Sertoli cells and a radiolabeled SRE oligonucleotide re- 
sulted in retarded mobility of a DNA-protein complex. A gel shift with 
a SRE oligonucleotide containing an ETS domain resulted in a unique 
shift only detected in PModS-stimulated cells. PModS also promoted 
a gel shift with the SIE that is adjacent to the SRE on the c-fos 
promoter. The data imply that PModS can activate the c-fos promoter 
through the SRE and SIE. PModS caused a labeled activating protein 
1 (APl) oligonucleotide to form a DNA-protein complex, indicating 
activation of the c-fos gene and binding of the c-fosljun complex. To 
study the downstream regulation of Sertoli cell differentiation, Tf 
gene expression was examined. CAT constructs containing deletion 
mutants of a 3-kilobase (kb) mouse Tf promoter were used. When 
transfected into Sertoli cells the 581-base pair Tf minimal promoter 
had only a slight response to PModS, but was activated by FSH. The 
2.6-kb Tf promoter construct responded to PModS. This response was 
greater than that observed with the 1.6- or 3-kb Tf promoter con- 
structs. These results suggest that an upstream enhancer located in 
the Tf promoter between -2.6 and -1.6 kb is responsive to PModS. 
Gel retardation assays with two restriction fragments, designated 
SE1 and SE2, located at -2.4 and -1.9 kb, respectively, on the Tf 
promoter showed a retarded complex with PModS-stimulated Sertoli 
cell nuclear extracts. No other restriction enzyme fragment of the Tf 
promoter was found to cause a gel shift. These SE1 and SE2 domains 
are in a region with apparent enhancer activity and were found not 
to contain a c-fosljun API-binding site. An immunoblot with c-fos 
antibodies of the SE1 and SE2 gel shift indicated the absence of c-fos 
in the DNA-protein complex. Therefore, PModS-responsive cis-ele- 
ments on the Tf promoter were identified (i.e. SE1 and SE2) that do 
not appear to involve a direct activation by c-fos at APl, but involve 
an intermediate c-fos-regulated transcription factor(s). The findings 
suggest that PModS acts through activation of the SRE and SIE to 
induce the immediate early gene, c-fos, which then influences an 
intermediate transcription factor(s) that regulates downstream Ser- 
toli cell differentiated functions, such as Tf expression. These studies 
have initiated an investigation of the transcriptional regulation of 
Sertoli cell differentiation. (Endocrinology 136: 3046-3053, 1995) 
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myoid cells that surround the tubule. Analysis of mesen- 
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the local production of a mesenchymal factor, termed PModS 
(1,2). The testicular paracrine factor, PModS, is produced by 
the peritubular myoid cells under androgen control and 
modulates Sertoli cell differentiated functions in vitro (1, 2). 
Among these differentiated functions is the synthesis of the 
iron-binding protein, transferrin (Tf) (3,4). Tf expression has 
been used as a marker of Sertoli cell differentiation during 
pubertal development (4). To investigate the pharmacology 
of PModS, several common signal transduction pathways 
were analyzed. PModS was found to have no effect on CAMP 
levels (4) or on calcium mobilization or phosphoinositide 
metabolism (5). Although PModS was found to elevate 
cGMP, cGMP does not mediate the actions of PModS (5). 
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Treatment of Sertoli cells with the tyrosine phosphorylation 
inhibitor, genistein, suppresses PModS-stimulated Tf pro- 
duction (5). Therefore, the actions of PModS on Sertoli cells 
appear to be in part through an activation of tyrosine ki- 
nasefs). Regulation of Sertoli cell differentiation by PModS 
on a molecular level has also been investigated. An inhibitor 
of translation, cycloheximide, was used to determine 
whether PModS could directly stimulate Tf messenger RNA 
(m&WA) expression or whether intermediate protein syn- 
thesis was involved. Cycloheximide inhibited PModS-in- 
duced Tf mRNA synthesis, indicating that activation of im- 
mediate early genes is required for stimulation of Tf 
expression (6). Northern analysis of potential immediate 
early genes demonstrated that PModS stimulates c-fos 
mRNA synthesis, but has no effect on two other nuclear 
proteins c-jun and C/EBP. The protein c-fos is a protoonco- 
gene that is transiently stimulated by a variety of mitogens 
and differentiation factors (7). Time-course data show that 
c-fos mRNA levels increase within minutes after PModS 
treatment and subsequently decline to basal levels after 2 h. 
In contrast, PModS-induced increases in Tf mRNA do not 
occur until 2 h, then peak at approximately 12 h, and are 
maintained for up to 5 days in culture. Treatment of Sertoli 
cells with a c-fos antisense oligonucleotide partially sup- 
presses PModS-enhanced Tf protein production (6). These 
data indicate that c-fos is involved as an immediate early gene 
in response to PModS. The current study was designed to 
analyze PModS activation of the c-fos promoter and relate 
this to the previous data on signal transduction and Sertoli 
cell differentiation. Activation of the Tf promoter was inves- 
tigated as a downstream event involved in Sertoli cell 
differentiation. 
Materials and Methods 
Cell preparation and culture 
Sertoli cells were isolated from the testis of 20-day-old rats by se- 
quential enzymatic digestion (8), with a modified procedure described 
by Tung et al. (9). Decapsulated testicular fragments were digested first 
with trypsin (1.5 mg/ml; Gibco-BRL, Gaithersburg, MD) to remove the 
interstitial cells and then with collagenase (1 mg/ml type I; Sigma 
Chemical Co., St. Louis, MO) and hyaluronidase (1 mg/ml; Sigma). 
Sertoli cells were then plated under serum-free conditions in 24-well 
Falcon plates at 1 X 106~cells/well. Cells were maintained in a 5% CO, 
atmosuhere in Ham’s F-12 medium (Gibco-BRL) at 32 C. Sertoli cell 
cultures were treated as described in Results, after 48 h of culture and 
transfection. Cultures were treated with FSH (100 rig/ml; ovine FSH-16, 
National Pituitary Agency), (Bu),cAMP (1 mM1, 10% calf serum, or 
greater than maximally effective concentrations of PModS(S300) 
(25 Kg/ml) or PModS(C4) (25 rig/ml). 
Peritubular cells were obtained from the collagenase digestion su- 
pernatant, as described by Skinner et al. (21, after the tubule segments had 
sedimented. Peritubular cells were plated in Ham’s F-12 medium con- 
taining 10% calf serum and grown to confluence. Cells were then sub- 
cultured and plated at 25% confluence. When subcultured cells were 
I  
confluent, they were washed with serum-free medium. The cells were 
subsequently cultured in serum-free medium for up to 4 weeks with 
48- to 72-h medium collections. 
Freshly collected serum-free conditioned medium from the peritu- 
bular cells was treated with phenylmethylsulfonylfluoride (25 FM final 
concentration) and benzamidine (0.1 mM final concentration) and cen- 
trifuged at 1000 X g for 15 min at 4 C to remove cell debris. When 
necessary, medium was stored at -20 C. Conditioned medium was 
concentrated loo-fold by ultrafiltration with an Amicon system (Amicon 
Corp., Lexington, MA) and a 3000 mol wt exclusion limit membrane. 
PModS preparation 
PModS was obtained from concentrated peritubular cell-conditioned 
medium, as previously described (2). An ammonium sulfate precipitate 
of concentrated conditioned medium was applied to a size-exclusion 
Sephacryl S300 column (Pharmacia, South San Francisco, CA). The ac- 
tive peak of the 5300, determined by bioassay of Sertoli cell Tf produc- 
tion, was collected and applied to a chromatofocusing column (Phar- 
macia). The pH 5.7-6.8 pool was applied to a 1 X 15.cm heparin- 
Sepharose affinity column. Eluted proteins were applied to two 
successive C4 reverse phase columns (Vydac, Hesperia, CA) and eluted 
with a linear gradient-from 25-60% acetonitrile. The partially purified 
PModS 5300 pool, termed PModS(S300), and the more highly purified 
PModS(C4) fraction, termed I’ModS(C4), were stored at -70 C before 
use in the presence of 1 mg/ml BSA. 
Reporter gene constructs 
c-Fos promoter. The chloramphenicol acetyltransferase (CAT) reporter 
plasmids (PBL-CAT2) with the thymidine kinase minimal promoter (10) 
containing either the CAMP response element (CRE) [120-base pair (bp) 
5’-flanking sequence from the transcriptional start site of the human c-fos 
promoter with a 5’-TGACGTTT-3’ sequence at -60 bpl, TPA/activating 
protein 1 (APl) response element (TRE; 5’-TGCGTCA-3’1, or the serum 
response element (SRE; 5’-CAGGATGTCCATATTAGGACATC-3’) se- 
quences of the c-fos promoter were generated; the entire c-fos promoter 
was generously provided by Dr. Jeff Holt (Vanderbilt University, Nash- 
ville, TN). The sis-inducible element (SIE)-CAT reporter plasmid was 
constructed by cloning a synthetic 15-bp oligonucleotide (CATTTC- 
CCGTAAATC) (11) with Hind111 and SphI sites on either ends into 
PBLCAT2 plasmid. The SIE/SRE construct was prepared by cloning the 
15-bp SIE oligo into HindIII/SphI sites of the SRE-CAT plasmid. 
Tfpromoter. The CAT reporter plasmid containing -581 bp (PUC8 CAT) 
and the human GH reporter plasmid containing -3.0-kilobase (kb) 
sequences of the mouse Tf (mTfl promoter (12) were generously pro- 
vided by Dr. G. Stanley McKnight (University of Washington, Se- 
attle, WA). The CAT reporter plasmids containing -3.O-kb mTf pro- 
moter and its deletions were constructed as follows. 1) The 3.0-kb mTf 
CAT construct was made by ligating a -3.O-kb BarnHI-BumHI digest to 
the BamHI site in PGL2-CAT plasmid (Promega). 2) The 2-kb upstream 
HindIII-Hind111 fragment in the 3-kb mTf promoter was ligated in the 
Hind111 site of -581-bp mTf-CAT to obtain the 2.6-kb mTf-CAT plasmid. 
3) The -1.6-kb mTf CAT plasmid was derived from the -3.O-kb mTf 
CAT (no. 1 above) by digesting out the upstream - 1.4-kb PstI fragment. 
4) To prepare the upstream l-kb mTf-CAT (I-kb Tf-Tk-CAT), the 3-kb 
mTf plasmid was digested with HindIII-PstI. The I-kb fragment (1.6-2.6 
kb) was then cloned into a I’BL-CAT2 plasmid. 
Constructs for each of the plasmids that did not contain the specific 
response element or promoter fragment (i.e. promoterless plasmid) were 
also generated. In all cases, experiments were performed to examine the 
actions of various treatments on these promoterless plasmids. As dis- 
cussed in Results, these promoterless plasmids generally did not respond 
to the treatments. If a small response was observed, the data are shown 
in the figures or stated in Results. 
Transfection 
Sertoli cells, cultured for 48 h, were transfected with a reporter gene 
construct by the calcium phosphate method coupled with hyperosmotic 
shock (10% glycerol), as previously described (131. Cells were treated 2 
h after transfection, and unless otherwise stated, CAT activity was 
determined after 48 h in culture. 
CAT assay 
Assay of CAT activity was performed as follows. Medium was re- 
moved from the wells, and the cells were washed once with PBS. One 
hundred microliters of 1 X cell lysis buffer (Promega Corp., Mad-  
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ison, WI) were added to each well and incubated for 15 min at room 
temperature. The wells were then scraped, and the buffer was collected 
in 1.5-ml microfuge tubes. Tubes were heated to 65 C for 10 min to 
inactivate endogenous acetylases and then spun at 12,000 X ,Q for 10 min 
at 4 C to remove cell debris. An aliquot of c&l extract (54 PlFwas mixed 
with 65 ~10.25 M Tris (pH 8.0), 25 pg n-butyryl coenzyme A (5 mg/ml; 
Sigma), and 0.1 PCi [‘4C]chloramphenicol (0.1 &i/PI; ICN, Costa 
Mesa, CA) and incubated overnight at 37 C. The mixture was extracted 
once with 300 ul xvlene and back-extracted with 100 ~10.25 M Tris (PH 
8.0). A 200-ml &iq;ot of the organic phase was counted in a scintilladon 
counter to determine the relative amount of CAT activity. 
Gel mobility shift assay 
Gel shift assays were performed with nuclear extracts of isolated 
Sertoli cells. The Sertoli cells were isolated as described above and 
cultured in 137-mm petri dishes (Falcon Plastics, Oxnard, CA). The cells 
were treated after 48 h in culture either FSH, PModS(S300), or 10% calf 
serum. After 72 h, the cells were scraped off the petri dishes and washed 
once with PBS. The nuclear extracts of these cells were then prepared as 
described by Guillou et al. (14). The probes used in gel retardation assays 
were the SRE (5’-GGATGTCCATATTAGGACACATCTG-3’) and the 
ETS-SRE element (SRE with 5’-CAGGAT sequence) of the c-fos pro- 
moter; the SIE (5’-CATITCCCGTAAATC-3’) located 25 bp upstream of 
the c+s SRE (15), and API dimer (5’-TTAGTCATGAGTCA-3’). The 
complementary oligonucleotides were 5’-end labeled with I~321’lATP 
(150 /.&I/d; New England Nuclear Corp., Boston, MA) using polynu- 
cleotide kinase, annealed, and subsequently purified on a 12% poly- 
acrylamide gel. 
Restriction fragments of the mTf promoter between -581 bp and -3 
kb were obtained with a series of enzvmes. including PvuII. NarI. HPuI. 
and PstI. Fifteen approximately 2OOtbp fragments “were isolated, ‘de: 
phosphorylated, and end labeled with [~32P]ATP using polynucleotide 
kinase. Of these fragments, two gave a positive gel shift. The restriction 
fragments SE1 (200 bp) and SE2 (180 bp) were located at -2.4 and -1.9 
kb, respectively, on the 3-kb mTf 5’-flanking region. These two Tf pro- 
moter fragments (i.e. SE1 and SEZ) were routinely isolated, dephospho- 
rylated, and end labeled with [y-32P]ATP for gel shift analysis. 
The gel retardation assay used was a modification of the protocol 
described by Garner and Rezvin (15). The final reaction volume of 20 ~1 
contained 0.5 ng 5’-end 32P-labeled double stranded probe, 100 ng son- 
icated salmon sperm DNA, 2 LLP. DNA duplex poly(dI-dC) (U.S. Bio- 
chemical Corp.,*Cleveland, OF&-20 pg B’S& 20 ~M~HEPES (pH 8.0), 4 
mM Tris (uH 7.9). 50 mM KCl. 600 ILM EDTA (uH 8.0). EGTA (DH 8.0). 
500 PM &hioth&tol, and 5 bg S&toli cell &ear proteins. After in: 
cubation at room temperature for 20 min, 5 ~1 of the reaction were 
electrophoretically separated on a 5% polyacrylamide gel. The gel was 
dried and autoradiozravhed. For the competition experiments, a 500- 
fold molar excess of\niabeled oligonucle&ide or res’triction fragment 
was added to the binding reaction. 
Antisense procedure 
A c-jos antisense oligonucleotide, 3’-TACTACGGTGCA-5’, was pre- 
pared and used, as previously described (16, 17). A c-jos sense oligo- 
nucleotide was prepared for use as a negative control. Transfected 
Sertoli cells were treated with either the antisense or sense oligomer (4 
PM) starting 8 h after transfection and retreated every 8 h for a total of 
48 h before harvest of the cells for CAT assay. 
Immunoblot procedure 
A gel mobility shift assay was electrophoretically transferred to a 
polyvinylidone difluoride membrane (Immobilon Millipore, South San 
Francisco, CA) by electrophoresis in Tris-glycine buffer containing 20% 
methanol. The blot was then blocked with 3% nonfat milk [dissolved in 
50 mM Tris (pH 7.4), 150 mM NaCl, and 0.05% Nonidet P-401 and 
incubated with a 1:5000 dilution of antibody to c-fos (Santa Cruz Bio- 
technology, Santa Cruz, CA) for 2 h. After three washes (15 min each), 
the blot was hybridized with a secondary antibody (1:3000 dilution; 
directed against rabbit immunoglobulin G) conjugated to horseradish 
peroxidase for 1 h at room temperature. After five washes under the 
conditions described above, detection of the immune complex was per- 
formed using the chemiluminescent ECL method (Amersham Corp., 
Arlington Heights, IL). 
Statistical analysis 
Each data point was converted to a percentage of the control value, 
and the mean and SEM from multiple experiments were determined, as 
indicated in the figure legends. Data were analyzed by analysis of 
variance, using the SPSS Statistical Package (SI’SS, Chicago, IL). 
Results 
To confirm that c-fos is involved at a molecular level in 
PModS stimulation of Tf, a CAT reporter gene construct 
containing -2.6 kb of the Tf gene promoter was transiently 
transfected into cultured Sertoli cells. Sertoli cells were iso- 
lated from 20-day-old rat testis and cultured under serum- 
free conditions unless otherwise stated. After transfection, 
the cells were left untreated (control) or were treated with 
FSH, a partially purified PModS preparation from a size- 
exclusion column termed PModS(S300), a combination of 
PModS(S300) and the antisense c-jos oligonucleotide 
(S300+ANTI), or a combination of PModS(S300) and the 
sense c-fos oligonucleotide (S300+SENSE) for 48 h before 
analysis of the cell extracts for CAT activity. FSH, S300, and 
S300+SENSE activated the Tf CAT construct (Fig. 1). A con- 
trol promoterless plasmid (pCAT-basic) was slightly stimu- 
lated by PModS(S300) treatment. Treatment of the trans- 
fected cells with the antisense oligonucleotide inhibited 
PModS(S300)-induced CAT activity (Fig. 1). These data con- 
firm that c-fos is involved in PModS-stimulated Tf gene ex- 
pression. 
c-Fos promoter analysis 
To determine how PModS activates c-fos gene expression, 
CAT reporter gene constructs containing different regulatory 
% Control (CAT Activity) 
0 250 500 750 1000 1250 1500 
Control 
3 
pCAT-basic-S300 
2 
Ti s300 
$ 
2 
S3OO+Sense 
;: 
x 
u 
S’JOO+Anti 
FSH 
FIG. 1. Regulation of the 2.6-kb Tfpromoter-CAT construct in Sertoli 
cells cultured in the absence (control; C) or presence of FSH, 
PModS(S300), PModS(S300) and c-fos antisense oligonucleotide 
@3OO+ANTI), and PModS(S300) and c-fos sense oligonucleotide 
(S300+SENSE). The actions of PModS(S300) on a control pCAT-basic 
plasmid are also presented. Data are expressed as a percentage of the 
control and are presented as the mean t SEM from three different 
experiments performed in replicate. ***, Statistical difference from 
S300 or SBOO+SENSE (P < 0.01). 
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elements of the c-jos promoter were generated, including the 
CRE, TRE, SIE, and SRE. A schematic representation of the 
locations of these elements within the c-fos promotor is 
shown in Fig. 2A. These constructs were transiently trans- 
fected into cultured Sertoli cells. After transfection, the cells 
were left untreated (control) or were treated with FSH, 10% 
calf serum, (Bul,cAMP, PModS(S3001, or more highly puri- 
fied PModS preparations from the C4 reverse phase column 
termed PModS(C4) for 48 h. The CRE of the c-jos promoter 
was activated by both FSH and (Bu),cAMP 400% above the 
control level (P < 0.051, which demonstrated that the reporter 
construct can be activated (data not shown). Treatment with 
PModS(S300) did not increase CRE-CAT activity above the 
control level (Fig. 2Bl. Treatment of the c-fos TRE-transfected 
cells with FSH resulted in a 300% stimulation above the 
control level (P < 0.051, which demonstrated that this re- 
porter construct can be activated (data not shown). Treat- 
ment of the transfected Sertoli cells with PModS(S300) does 
not stimulate the TRE construct (Fig. 28). A SRE construct 
was used that included the 5’-flanking 5-bp ETS domain 
ETS-SRE sequence of the c-fos promoter. Activation of the 
c-fos SRE construct was accomplished by treatment with 10% 
calf serum as a positive control to demonstrate that the re- 
porter construct can be activated (data not shown). Both 
PModS(S300) and PModS(C4) activated the SRE construct 
(Fig. 2B). The SIE construct was also stimulated by 
PModS(S3001 and PModS(C4) (Fig. 2B). Interestingly, a con- 
struct containing both the SIE and SRE was stimulated to the 
a 
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-260 
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FIG. 2. a, Schematic representation of the c-fos promoter and the 
locations of the CRE, SRE, SIE, and TRE in promotor-CAT constructs. 
The designation for the promoter constructs is listed at the left, and 
that for the plasmid used at the right. b, Regulation of the c-fos 
promoter constructs (CRE, TRE, SIE, and SRE) in Sertoli cells cul- 
tured in the absence (control) or presence of PModS(S300) (m) and 
PModS(C4) (@. Data are expressed as a percentage of the control and 
are presented as the mean t SEM from six different experiments 
performed in replicate. 
same or lesser degree as that containing either element alone. 
The entire 400-bp c-fos promoter construct was stimulated 
approximately 900% over the control level by PModS(S300) 
(data not shown). The control plasmids not containing a 
promoter were not influenced by any of the treatments (data 
not shown). Purified PModS had a similar action as the 
partially purified PModS(S300). This indicates that stimula- 
tion of c-fos expression by PModS is in part mediated through 
activation of the SRE and SIE. 
To extend these observations, gel retardation/mobility 
shift assays were performed. Nuclear extracts were obtained 
from Sertoli cells cultured in the absence (control) or presence 
of PModS(S300) or 10% (vol/vol) calf serum as a positive 
control. A gel shift with an oligonucleotide to Ott-1 was used 
to check the quality of the nuclear extracts (Fig. 3). All extracts 
resulted in a similar level of Ott-1 gel shift. To confirm that 
c-fos was induced, a gel shift with an AI’1 oligonucleotide 
was performed, because the c-fos-jun complex binds to the 
AI’1 site. Incubation of the labeled API oligonucleotide with 
nuclear extracts of Sertoli cells treated with PModS6300) or 
serum resulted in the formation of a DNA-protein complex 
with retarded mobility (i.e. gel shift). The observed gel shift 
was specific for Al?, because it could be effectively com- 
peted by unlabeled AI’1 (Fig. 3). This confirms the induction 
of c-fos by both PModS(S300) and serum. 
Activation of SRE of the c-fos promoter was also investi- 
gated with a gel mobility shift assay using a SRE oligonu- 
cleotide (Fig. 4A). PModS(S300) induced a gel shift that was 
competed with excess unlabeled SRE. Serum was used as a 
positive control and also promoted a gel shift. To assess 
whether PModS may promote binding of a ternary complex, 
an ETS-SRE sequence was used in a gel shift. The ETS domain 
is a 5’-CAGGAT flanking sequence of the SRE that is needed 
for the binding of ETS oncogene-like proteins and is required 
for the formation of a ternary complex with the serum re- 
sponse factor (SRF) that binds to the SRE. PModS6300) pro- 
moted a distinct shift with the ETS-SRE that was not present 
in control nontreated cells or in serum-treated cells (Fig. 4Al. 
PModS(S300) promoted two distinct gel shifts, whereas se- 
rum promoted a diffuse shift below that of PModS(S300). 
These gel shifts were displaced with excess unlabeled oli- 
gonucleotide (data not shown). Therefore, PModS6300) in- 
duced protein binding to the SRE and ETS-SRE oligonucle- 
otides. An alternate response element, located 25 bp 
Treatment c P S CPPS s 
Unlabelld Excess - - - - - API - API 
OCTI API 
FIG. 3. Cal mobility shift assay with 32P-radiolabeled Ott-1 and APl 
oligonucleotides. Nuclear extracts from Sertoli cells cultured in the 
absence (C)or presence of PModS(S300) (P) or 10% calf serum (S) were 
used. The DNA-protein complexes were electrophoretically separated 
on 5% polyacrylamide gels, then dried and autoradiographed. The 
data are representative of five different experiments. 
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Treatment C P PS s PSC 
Unlabeiled Excess - - SRE - SRE - - - 
* 
b 
SRE ETS-SRE 
Treatment c P P s s 
Unlabekd Excess _ _ SIE - SIE 
SIE 
FIG. 4. Gel mobility shift assay with 32P-radiolabeled SRE and ETS- 
SRE (a), and SIE (b) oligonucleotides. Nuclear extracts from Sertoli 
cells cultured in the absence (0 or presence of PModS(S300) (P) or 
10% calf serum (S) were used. The DNA-protein complexes were 
electrophoretically separated on 5% polyacrylamide gels, then dried 
and autoradiographed. The data are representative of 10 different 
experiments for SRE and 5 different experiments for SIE. 
upstream from the SRE, is the SIE, which is also responsive 
to serum. A SIE oligonucleotide gel shift demonstrated that 
PModS(S300) promotes a SIE gel shift (Fig. 48). Again, serum 
was used as a positive control and promoted the anticipated 
gel shift. This SIE gel shift was specific and could be com- 
peted by excess unlabeled SIE oligonucleotide. Previously, a 
SIE gel shift has been shown to involve three shifts, termed 
A, 8, and C. PModS was found to promote all three forms, 
with A (lowest) being the predominant (Fig. 4B). The gel shift 
data presented confirm the reporter gene experiments pre- 
viously discussed. Therefore, PModS appears to act through 
the SRE and SIE to promote c-fos gene expression. 
Tfpromoter analysis 
To determine the location of response elements within the 
Tf promoter that are activated by treatment with PModS, 
four CAT constructs containing a 581-bp, 1.6-kb, 2.6-kb, or 
3-kb upstream region of the Tf promoter were produced (Fig. 
5A). FSH treatment of cells transfected with any of the con- 
structs, except the 2.6- to 1.6-kb Tf PBL-CAT2, termed I-kb 
Tf-Tk-CAT, stimulated CAT activity approximately 400% 
above control values, confirming that these constructs can be 
activated (data not shown; P < 0.01). PModS(S300) treatment 
induced activation of the -581-bp, -1.6-kb, and -3-kb Tf 
constructs (Fig. 58) to a similar extent. The -2.6-kb Tf con- 
struct was stimulated to a greater extent by PModS(S300) 
(Fig. 58). Interestingly, the PModS(C4) preparation stimu- 
a 
SE1 SE2 CRE -- 
PGU-CA T  
pUCECAT 
PBL-CAT2 
PGL2-CAT 
PUCE-CAT 
-3.Okb -2.6kb -1.6kb -561bp 
b 
0 
”  
-5Rlbp -1.6Kb -2.6Kb -3.OKb 
construct 
FIG. 5. a, Schematic representation of the Tf promotor-CAT con- 
structs and location of CRE, SEl, and SE2 regions. b, Regulation of 
the various Tfpromotor-CAT constructs in Sertoli cells cultured in the 
presence of PModS(S300) (a) and PModS(C4) (W. Data are expressed 
as a percentage of the value in control nontreated cells for .each 
construct. Data are representative of three different experiments 
performed twice. 
lated primarily the -2.6-kb Tf construct. This indicates that 
an enhancer-like activity involved in PModS stimulation of 
Tf production is located between -1.6 and -2.6 kb, and a 
repressor is located between -2.6 and -3 kb of the promoter. 
To extend these observations, the lOOO-bp region of the pro- 
moter between - 1.6 and -2.6 kb was cloned into a Tk-CAT 
construct (PBL-CAT2; Fig. 5A), termed lkb Tf-Tk-CAT. 
PModS was found to activate this construct, but had only a 
slight effect on the control plasmid not containing the I-kb 
Tf promoter (Fig. 6). PModS(C4) had an action similar to that 
of the partially purified PModS(S300). The plasmid used 
contained a minimal thymidine kinase (Tk) promoter with a 
TATA box (Tk-CAT) that was required for PModS to activate 
this l-kb Tf construct. In the absence of a minimal promoter 
with a TATA box, a similar construct was not activated (data 
not shown). Therefore, the ability of PModS to activate the 
enhancer elements in this Tf promoter fragment does require 
a minimal promoter containing a TATA box. 
Although the region between 0 and -581 bp has been 
sequenced and mapped, little is currently known about the 
distal region of the Tf promoter. Therefore, the exact nature 
of these putative upstream regulatory elements is unknown. 
To initiate an examination of this region, the entire 2.5-kb 
fragment of the Tf promoter between -581 bp and -3 kb was 
digested with various restriction enzymes to generate 15 
approximately 200-bp fragments. These fragments were 
used in gel mobility shift assays to identify potential PModS- 
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Constn,c; IKbTf--%&AT TIccAT - IKbTf-TI-CAT- 
Treatment COll@Ol s300 s300 c4 
FIG. 6. Regulation of a 1-kb fragment of the Tf promoter between 
- 1.6 kb and -2.6 kb containing SE1 and SE2 inserted into a Tk-CAT 
Dlasmid and termed 1 kb Tf-Tk-CAT. Sertoli cells were cultured in the 
absence (C) or presence of PModS(S300) or PModS(C4). The actions 
of PModS(S300) on a control Tk-CAT plasmid are also shown. Data 
are expressed as a percentage of the value in control nontreated cells 
for each construct and are presented as the mean +- SEM from three 
different experiments performed twice. ***, Statistically significant 
difference from the control (P < 0.01). 
responsive regions. Thirteen of these Tf promoter restriction 
fragments did not cause a gel shift under control or PModS- 
stimulated conditions (data not shown). Two restriction frag- 
ments upstream of the mTf transcriptional start site located 
at -2.4 kb, designated SEI, and at -1.9 kb, designated SE2, 
did cause a gel shift after PModS stimulation (Fig. 7). The 
location of these Sertoli elements (i.e. SE1 and SE2) on the Tf 
promoter is diagrammatically shown in Fig. 5A. To deter- 
mine whether either SE1 or SE2 is a potential APl-binding 
site, a competition experiment was carried out with excess 
unlabeled AI’1 oligonucleotide. The unlabeled API was not 
able to displace the SE1 or SE2 complex. Therefore, the gel 
shift appears not to be due to a c-fos/jun-binding AI’1 site. The 
SE2 fragment was unable to form the DNA-protein complex 
with the nuclear extracts of Sertoli cells treated with serum 
(Fig. 7). PModS(S300) caused a gel shift with both SE1 and 
SE2 that was competed with excess unlabeled oligonucleo- 
tide (Fig. 7). Excess SE2 DNA fragment did not compete for 
the SE1 complex, nor did the SE1 compete for the SE2 com- 
plex. These two, apparently distinct, non-APl-containing re- 
gions of the Tf promoter appear to be influenced by PModS 
actions on Sertoli cells. 
FIG. 7. Gel mobility shift assay with 
32P-radiolabeled SE1 and SE2 regions 
of the Tf promoter. Nuclear extracts 
from Sertoli cells cultured in the ab- 
sence (C) or presence of PModS(S300) 
(P) or 10% calf serum (S) were used. The 
DNA-protein complexes were electro- 
phoretically separated on 5% polyacryl- 
amide gels, then dried and autoradio- 
graphed. Incubations with excess 
unlabeled SEl, SE2, or APl are indi- 
cated. The data are representative of 
four different experiments. 
Treatment C p 
- - 
To confirm that c-fos does not associate with the PModS- 
induced SE1 and SE2 gel shifts, an immunoblot with a c-fos 
antiserum of the gel shifts was performed (Fig. 8). Although 
a gel shift was detected with both SE1 and SE2, c-fos was not 
detected in the DNA-protein complex (Fig. 8). A positive 
control API gel shift did contain c-fos in its DNA-protein 
complex (Fig. 8). These observations imply that c-fos regu- 
lates an intermediate transcription factor(s) that influences 
the Tf promoter at SE1 and SE2 (Fig. 9). 
Discussion 
The ability of the antisense c-fos oligonucleotide to inhibit 
PModSinduced activation of the Tf promoter in Sertoli cells 
transfected with the -2.6-kb Tf-CAT reporter construct corre- 
lates with its ability to inhibit Tf protein secretion (6). These data 
demonstrated that c-fos is involved in PModS stimulation of Tf 
expression by cultured Sertoli cells. To further investigate the 
actions of PModS on a molecular level, the effects of PModS on 
both the c-fos and Tf promoters were examined. 
c-Fos promoter analysis 
The responses of Sertoli cells treated with PModS and 
transfected with the reporter constructs containing the dif- 
ferent regulatory elements of the c-fos promoter correlated 
with previous data obtained on the pharmacology of PModS. 
Treatment of cultured Sertoli cells with PModS did not affect 
CAMP levels (4), nor was it able to stimulate the reporter 
construct with the CRE of the c-fos promoter. The inability of 
PModS(S300) treatment to activate the TRE supports the 
observation that PModS does not stimulate either calcium 
mobilization or phosphoinositide turnover (5), both markers 
of protein kinase C activation. The inability of PModS to 
influence the TRE and APl (i.e. FAP) site at -290 bp of the 
c-fos promoter supports previous findings that PModS ac- 
tions do not involve calcium mobilization or protein kinase 
C activation (5). Only the SRE and SIE were stimulated by 
treatment with the PModS(S300) and the highly purified 
PModS(C4) preparations. Interestingly, the presence of both 
SRE and SIE was not additive; the effect was the same or 
lesser than that of either element alone. Therefore, the ability 
of PModS to induce c-fos expression appears to be through 
the activation of SRE and SIE. 
The SRE is a 29-bp region within the c-fos promoter. A 
67-kilodalton protein has been isolated that binds to the SRE, 
the SRF (18). Evidence indicates that the binding of SRF to 
PPSSSS CPP PS 
E2 API - El E2 API - - E2 AF’l - 
  
3052 TRANSCRIPTIONAL REGULATION OF SERTOLI DIFFERENTIATION Endo. 1995 Vol 136. No 7 
PS P s P P PS P s 
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Blot Gel Shift Blot Gel Shift Blot Gel Shift 
APl SE2 SE1 
FIG. 8. Immunoblot of an APl, SEl, and SE2 gel mobility shift assay 
with a c-fos antiserum. Nuclear extracts from Sertoli cells cultured in 
the presence of PModS(S300) (P) or 10% calf serum (S) were used. The 
DNA-protein complexes were electrophoresed and separated on 5% 
polyacrylamide gels, then either dried and autoradiographed (Gel 
Shift) or electrophoretically blotted to polyvinylidene difluoride mem- 
brane and immunoblotted with the c-fos antiserum (Blot). The data 
are representative of two experiments. 
SRE requires its phosphorylation (19-21). The actions of 
PModS require tyrosine phosphorylation events (5). The 
DNA-binding domain of SRF is the region necessary for 
dimerization and interaction with other proteins to form 
ternary complexes (18). Because SRF is ubiquitously ex- 
pressed, cell-specific activation of the c-fos SRE by SRF ap- 
pears to be mediated by other ternary complex protein fac- 
tors. The binding of the ternary complex to the SRE requires 
the presence of the adjoining 5’-side of the SRE-binding site, 
the ETS domain binding motif. The protein kinase C-depen- 
dent and -independent pathways target different parts of this 
ternary complex (22). The expression and/or phosphoryla- 
tion of these proteins may be involved in mediating cell- 
specific responses by the SRE. The SRE gel shift data pre- 
sented demonstrate that PModS induced a gel shift similar 
to that of the positive control with serum treatment. Under 
less stringent conditions, a SRE gel shift was detected in 
control cells, but a more abundant gel shift was present in 
PModS-treated Sertoli cells (data not shown). The identity of 
the PModS-induced SRE-binding protein as SRF or other 
binding proteins remains to be elucidated. Interestingly, 
PModS induced a unique gel shift with the ETS-SRE that was 
not observed in control nontreated cells or in serum-treated 
cells. Therefore, PModS appears to promote the binding of a 
protein complex (e.g. ternary complex) that activates the SRE 
within the c-fos promoter. The formation of these ternary 
complexes may enable a common regulatory element, such 
as the SRE, to have cell-specific activity using ubiquitously 
expressed DNA-binding proteins. Alternatively, different or 
unique binding factors may be another method by which a 
common regulatory element may differentially activate cell- 
specific gene expression. In support of this proposal, several 
P Mod S 
Phosphbtylation 
FIG. 9. Schematic of the proposed mo- 
lecular actions of PModS to regulate 
Sertoli cell differentiation. 
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other DNA-binding factors have been identified that interact 
with the SRE. The 62-kilodalton SRE direct binding factor 
(~62~~~) may be related to the MAPFl protein isolated from 
yeast (23). This factor is phosphorylated in vivo and mediates 
muscle-specific expression of a-actin. SRE-zinc-binding pro- 
tein is a member of the C2H2 zinc finger family (24). High 
affinity binding is achieved through seven tandemly re- 
peated zinc finger motifs. Rat NFIL-6 is a C/EBP-related 
factor whose binding to the SRE is mutually exclusive with 
SRF (25). Further analysis of activation of the SRE by PModS 
will investigate the potential involvement of known ternary 
complex factors, unique ternary complex factors, or novel 
SRE-binding proteins. 
A second regulatory element that appears to be involved 
in PModS stimulation of c-fos is the SIE. It is located 25 bp 
upstream of the SRE. The SIE is activated by binding of the 
SIF, which has three forms, A, B, and C, and contains a 
phosphotyrosine residue (11). Treatment of human epider- 
moid carcinoma cells with epidermal growth factor and hu- 
man hepatoma cells with interleukind induces the binding 
of SIF-A, whereas treatment of epidermoid cells with inter- 
feron-y induced binding of SIF-C (11). This is also an example 
of the ability of different binding proteins to activate a com- 
mon regulatory element and stimulate a gene-specific re- 
sponse. PModS induced a SIE gel shift that appears to involve 
predominantly SIFtA), but also had detectable SIF(B) and 
SIF(C) gel shifts. PModS was also found to activate a SIE 
reporter construct. Interestingly, the effects of both the SIE 
and SRE were not additive in response to PModS. PModS 
appears to influence the c-fos promoter at both the SRE and 
SIE. Whether the SIE can compensate and/or regulate the 
SRE response remains to be elucidated. 
Tf promoter analysis 
The downstream effects of PModS-induced c-fos expres- 
sion were investigated with use of the Tf gene as a differ- 
entiated marker of Sertoli cells. The gene expression of Tf was 
inhibited by an antisense c-fos oligonucleotide, indicating 
that actions of PModS on the Tf promoter are indeed a down- 
stream c-fos event. The regions controlling liver-specific tran- 
scription of the human Tf gene are composed of multiple 
positive and negative acting elements, mostly interacting 
with DNA-binding proteins present in either human or rat 
liver nuclear extracts (26, 27). The regulation of Tf gene 
expression in unstimulated Sertoli cells has been shown to be 
distinct from that of liver gene expression (28). Although the 
first 581 bp of the human Tf promoter (hTf) and mTf pro- 
moter have little similarity, they both contain a CRE site,  
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which was found to be responsive to FSH in the current 
study. The results with the CAT-mTf deletion mutants sug- 
gest that an enhancer activity is located between -2.6 and 
-1.6 kb for PModS and a repressor between -2.6 and -3.0 
kb. Analysis of restriction enzyme fragments of the Tf pro- 
moter between -581 bp and -3kb identified two distinct 
domains, designated SE1 and SE2, that bind specific nuclear 
proteins from Sertoli cells stimulated with PModS. Interest- 
ingly, these Sertoli response elements (i.e. SE1 and SE2) are 
located within the apparent enhancer activity between -2.6 
and -1.6 kb of the Tf promoter. Treatment with serum also 
induced a similar DNA-protein complex with SEl. The com- 
plex formed with SE2 was specific to PModS(S300), because 
treatment with serum or CAMP (data not shown) could not 
induce the gel shift. The lack of competition of SE1 and SE2 
with AI’1 suggested that these sites were independent of APl 
and the binding of a c-fos-jun complex. The c-fos immunoblot 
confirmed the absence of c-fos in the SE1 and SE2 DNA- 
protein complexes. Therefore, PModS induced Tf gene ex- 
pression may involve both c-fos-dependent and -indepen- 
dent response elements. It is postulated that c-fos regulates 
the expression or activities of an intermediate transcription 
factor(s) that subsequently binds the SE1 and SE2 regions. 
The general mechanism is currently proposed, in that 
PModS, through activation of the SRE and SIE, induces the 
immediate early response gene c-fos, which then influences 
an intermediate transcription factor(s) that regulates down- 
stream Sertoli cell differentiated functions such as Tf gene 
expression. Future studies will involve elucidation of the 
precise mechanism by which PModS activates the SRE and 
SIE of the c-fos promoter and Sertoli cell-specific response 
elements (e.g. SE1 and SE2) of the Tf promoter. The possibility 
that Sertoli cell-specific trans-acting factors and ternary com- 
plex factors as well as unique response elements may be 
involved in the Sertoli cell-specific activation of these pro- 
moters is being investigated. 
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